Verity A. Saunders

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia.

Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia.

Journal: HemaSphere

Published: March 18, 2026

A Reliable Method for Thawing Primary AML and CMML Mononuclear Cells to Preserve Viability and Function.

A Reliable Method for Thawing Primary AML and CMML Mononuclear Cells to Preserve Viability and Function.

Journal: Bio-protocol

Published: March 17, 2026

Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and nilotinib.

Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and nilotinib.

Journal: Leukemia

Published: March 10, 2026

Independent living transitions for young people with cerebral palsy in Australia: aligning policy and practice with family realities.

Independent living transitions for young people with cerebral palsy in Australia: aligning policy and practice with family realities.

Journal: Frontiers in public health

Published: November 27, 2025

Families' perspectives of transitioning young adults with cerebral palsy to independent living.

Families' perspectives of transitioning young adults with cerebral palsy to independent living.

Journal: Disability and rehabilitation

Published: September 23, 2025

Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.

Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.

Journal: Blood

Published: June 06, 2025

Enhanced Detection of Splice-Altering Variants in Hematologic Malignancies Using Targeted RNA-Sequencing Data.

Enhanced Detection of Splice-Altering Variants in Hematologic Malignancies Using Targeted RNA-Sequencing Data.

Journal: The Journal of molecular diagnostics : JMD

Published: February 25, 2025

CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinib.

CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinib.

Journal: Blood neoplasia

Published: November 03, 2023

Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib.

Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib.

Journal: Blood cancer journal

Published: July 06, 2023

Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.

Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.

Journal: Blood

Published: May 12, 2023

The impact of climate change on country and community and the role of mental health professionals working with Aboriginal communities in recovery and promoting resilience.

The impact of climate change on country and community and the role of mental health professionals working with Aboriginal communities in recovery and promoting resilience.

Journal: International journal of mental health nursing

Published: February 09, 2023

Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines.

Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines.

Journal: International journal of molecular sciences

Published: January 20, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026